These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 26787900)
1. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Bhardwaj A; Das S Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E538-47. PubMed ID: 26787900 [TBL] [Abstract][Full Text] [Related]
2. Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma. Yang H; Zhu R; Zhao X; Liu L; Zhou Z; Zhao L; Liang B; Ma W; Zhao J; Liu J; Huang G Oncogene; 2019 Jun; 38(25):4915-4931. PubMed ID: 30858544 [TBL] [Abstract][Full Text] [Related]
3. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948 [TBL] [Abstract][Full Text] [Related]
4. SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth. Park SH; Ozden O; Liu G; Song HY; Zhu Y; Yan Y; Zou X; Kang HJ; Jiang H; Principe DR; Cha YI; Roh M; Vassilopoulos A; Gius D Cancer Res; 2016 Jul; 76(13):3802-12. PubMed ID: 27197174 [TBL] [Abstract][Full Text] [Related]
5. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Lv L; Xu YP; Zhao D; Li FL; Wang W; Sasaki N; Jiang Y; Zhou X; Li TT; Guan KL; Lei QY; Xiong Y Mol Cell; 2013 Nov; 52(3):340-52. PubMed ID: 24120661 [TBL] [Abstract][Full Text] [Related]
6. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599 [TBL] [Abstract][Full Text] [Related]
7. Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth. Xiangyun Y; Xiaomin N; Linping G; Yunhua X; Ziming L; Yongfeng Y; Zhiwei C; Shun L Oncotarget; 2017 Jan; 8(4):6984-6993. PubMed ID: 28036303 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells. Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169 [TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress. Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265 [TBL] [Abstract][Full Text] [Related]
10. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread. Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399 [TBL] [Abstract][Full Text] [Related]
11. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880 [TBL] [Abstract][Full Text] [Related]
12. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells. Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080 [TBL] [Abstract][Full Text] [Related]
13. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor. Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201 [TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression. Amin S; Yang P; Li Z Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427 [TBL] [Abstract][Full Text] [Related]
15. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation. Gao F; Zhang X; Wang S; Zheng L; Sun Y; Wang G; Song Z; Bao Y Cell Death Dis; 2021 May; 12(6):517. PubMed ID: 34016961 [TBL] [Abstract][Full Text] [Related]
16. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner. Kohli S; Bhardwaj A; Kumari R; Das S Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762 [TBL] [Abstract][Full Text] [Related]
17. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6. Wood M; Rymarchyk S; Zheng S; Cen Y Arch Biochem Biophys; 2018 Jan; 638():8-17. PubMed ID: 29233643 [TBL] [Abstract][Full Text] [Related]
18. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Yang W; Xia Y; Hawke D; Li X; Liang J; Xing D; Aldape K; Hunter T; Alfred Yung WK; Lu Z Cell; 2012 Aug; 150(4):685-96. PubMed ID: 22901803 [TBL] [Abstract][Full Text] [Related]
19. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis. Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689 [TBL] [Abstract][Full Text] [Related]